Lopres 100 mg Tablet is a prescription medicine with atenolol as its active ingredient. It is used in the management of high blood pressure, long-term angina, and certain heart attack patients, as directed by a doctor.
There are 59 brands of Atenolol listed in Bangladesh. 40 of them have a lower unit price than Lopres. The lowest listed price is Betanol 25 mg Tablet at ৳ 0.45 per unit.
What is Lopres 100 mg Tablet?
Lopres 100 mg Tablet is a beta-blocker medicine made by Orion Pharma Ltd. Its generic name is atenolol, and it belongs to the beta-adrenoceptor blocking drug class. Doctors prescribe it for managing hypertension, for long-term management of angina pectoris, and for haemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality. It works by blocking beta1 (cardiac) receptors selectively. Lopres comes as a tablet in a 100 mg strength. Only a registered physician should decide whether it suits you, and the dose and course are set by the doctor.
Uses of Lopres
Lopres 100 mg Tablet is used in the management of hypertension, either alone or together with other antihypertensive medicines such as thiazide-type diuretics. It is also used for long-term management of patients with angina pectoris. In addition, doctors may use it in haemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality. Your doctor will confirm whether this medicine is appropriate for your condition.
How to use Lopres
Lopres 100 mg Tablet is taken by mouth. The dose, timing and length of course are decided by your doctor, who will consider your condition and response to treatment. Do not change the dose or stop the medicine on your own, because stopping a beta-blocker suddenly can be harmful. If you miss a dose, ask your doctor or pharmacist what to do. Swallow the tablet as your doctor advises, and keep all medicines out of the reach of children.
Side effects of Lopres
As expected with any beta-blocker, bradycardia and hypotension occurred more commonly in investigations of acute myocardial infarction treatment. Other effects reported with beta-adrenergic blocking agents, which may be potential effects of atenolol, include blood-related changes such as agranulocytosis, and allergic reactions such as fever with aching and sore throat, laryngospasm and respiratory distress. Central nervous system effects reported include reversible mental depression and short-term memory loss. Tell your doctor if you notice any unusual symptoms while taking this medicine.
Safety and precautions
Lopres 100 mg Tablet is not for people with sinus bradycardia, heart block greater than first degree, cardiogenic shock, or overt cardiac failure, or those with a history of hypersensitivity to atenolol or any component of the product. Patients already on a beta-blocker need careful evaluation before atenolol is given. It should be used with caution in impaired renal function and may aggravate peripheral arterial circulatory disorders. It is Pregnancy Category D, and caution is needed during breastfeeding because clinically significant bradycardia has been reported in breast-fed infants. Ask your doctor first if you are pregnant, breastfeeding, elderly, or have kidney problems.
Frequently asked questions
What is Lopres 100 mg Tablet used for and what kind of medicine is it?
It is a beta-blocker (atenolol) used for managing hypertension, for long-term management of angina pectoris, and in haemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality. Your doctor will decide if it is suitable for you.
How should Lopres 100 mg Tablet be taken?
It is taken by mouth. The dose, timing and course are decided by your doctor based on your condition and response. Never change the dose or stop it on your own; ask your doctor or pharmacist if you are unsure about anything.
Which medicines may interact with Lopres 100 mg Tablet?
Interactions may occur with catecholamine-depleting drugs such as reserpine, calcium channel blockers, disopyramide and amiodarone. Tell your doctor or pharmacist about all medicines you take, including those bought without a prescription, so your treatment can be checked.
In the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic.
For the long-term management of patients with angina pectoris.
In the management of hemodynamically stable patients with defnite or suspected acute myocardial infarction to reduce cardiovascular mortality.
Pharmacology
The synthesis of atenolol resulted from attempts to produce a β-adrenoceptor antagonist that would competitively block β1 (cardiac) receptors but have no effect on β2-receptors. It is classified as a β1 selective (cardioselective) β-adrenergic receptor antagonist with no membranestability activity and no partial agonist activity. It is markedly the most hydrophilic of the currently available β- blockers and thus penetrates the lipid of cell membranes poorly
Dosage & Administration
Hypertension: The initial dose of Atenolol is 50 mg given as one tablet a day either alone or added to diuretic therapy. The full effect of this dose will usually be seen within one to two weeks. If an optimal response is not achieved, the dosage should be increased to Atenolol 100 mg given as one tablet a day. Increasing the dosage beyond 100 mg a day is unlikely to produce any further benefit.
Angina Pectoris: The initial dose of Atenolol is 50 mg given as one tablet a day. If an optimal response is not achieved within one week, the dosage should be increased to Atenolol 100 mg given as one tablet a day. Some patients may require a dosage of 200 mg once a day for optimal effect. Twenty-four hour control with once daily dosing is achieved by giving doses larger than necessary to achieve an immediate maximum effect. The maximum early effect on exercise tolerance occurs with doses of 50 to 100 mg, but at these doses the effect at 24 hours is attenuated, averaging about 50% to 75% of that observed with once a day oral doses of 200 mg.
Acute Myocardial Infarction: In patients with definite or suspected acute myocardial infarction, treatment with Atenolol I.V. Injection should be initiated as soon as possible after the patient's arrival in the hospital and after eligibility is established. Treatment should begin with the intravenous administration of 5 mg Atenolol over 5 minutes followed by another 5 mg intravenous injection 10 minutes later. In patients who tolerate the full intravenous dose (10 mg), Atenolol Tablets 50 mg should be initiated 10 minutes after the last intravenous dose followed by another 50 mg oral dose 12 hours later. Thereafter, Atenolol can be given orally either 100 mg once daily or 50 mg twice a day for a further 6-9 days or until discharge from the hospital. If bradycardia or hypotension requiring treatment or any other untoward effects occur, Atenolol should be discontinued.
Interaction
Catecholamine-depleting drugs (eg, reserpine) may have an additive effect when given with beta-blocking agents. Patients treated with Atenolol plus a catecholamine depletor should therefore be closely observed for evidence of hypotension and/or marked bradycardia which may produce vertigo, syncope, or postural hypotension.
Calcium channel blockers may also have an additive effect when given with Atenolol.
Disopyramide is a Type I antiarrhythmic drug with potent negative inotropic and chronotropic effects. Disopyramide has been associated with severe bradycardia, asystole and heart failure when administered with beta blockers.
Amiodarone is an antiarrhythmic agent with negative chronotropic properties that may be additive to those seen with beta blockers.
Beta blockers may exacerbate the rebound hypertension which can follow the withdrawal of clonidine. If the two drugs are coadministered, the beta blocker should be withdrawn several days before the gradual withdrawal of clonidine. If replacing clonidine by beta-blocker therapy, the introduction of beta blockers should be delayed for several days after clonidine administration has stopped.
Concomitant use of prostaglandin synthase inhibiting drugs, eg, indomethacin, may decrease the hypotensive effects of beta blockers.
While taking beta blockers, patients with a history of anaphylactic reaction to a variety of allergens may have a more severe reaction on repeated challenge, either accidental, diagnostic or therapeutic. Such patients may be unresponsive to the usual doses of epinephrine used to treat the allergic reaction.
Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. Concomitant use can increase the risk of bradycardia.
Contraindications
Atenolol is contraindicated in-
Sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure.
Those patients with a history of hypersensitivity to the atenolol or any of the drug product’s components.
Side Effects
In a series of investigations in the treatment of acute myocardial infarction, bradycardia and hypotension occurred more commonly, as expected for any beta blocker. In addition, a variety of adverse efects has been reported with other beta-adrenergic blocking agents, and may be considered potential adverse efects of Atenolol.
Hematologic: Agranulocytosis.
Allergic: Fever, combined with aching and sore throat, laryngospasm, and respiratory distress.
Central Nervous System: Reversible mental depression progressing to catatonia; an acute reversible syndrome characterized by disorientation of time and place; short term memory loss; emotional lability with slightly clouded sensorium; and, decreased performance on neuropsychometrics.
Miscellaneous: There have been reports of skin rashes and/or dry eyes associated with the use of beta-adrenergic blocking drugs. Discontinuance of the drug should be considered if any such reaction is not otherwise explicable. Patients should be closely monitored following cessation of therapy.
Other: Erythematous rash
Pregnancy & Lactation
Pregnancy Category D. Caution should be exercised when Atenolol is administered to a nursing woman. Clinically significant bradycardia has been reported in breast-fed infants. Premature infants, or infants with impaired renal function, may be more likely to develop adverse effects.
Precautions & Warnings
General: Patients already on a beta blocker must be evaluated carefully before Atenolol is administered. Initial and subsequent Atenolol dosages can be adjusted downward depending on clinical observations including pulse and blood pressure. Atenolol may aggravate peripheral arterial circulatory disorders.
Impaired Renal Function: The drug should be used with caution in patients with impaired renal function.
Geriatric Use:
Hypertension and Angina Pectoris: Due to Coronary Atherosclerosis: Dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
Acute Myocardial Infarction: Dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Evaluation of patients with hypertension or myocardial infarction should always include assessment of renal function.
Overdose Effects
Overdosage with Atenolol has been reported with patients surviving acute doses as high as 5 g. One death was reported in a man who may have taken as much as 10 g acutely. The predominant symptoms reported following Atenolol overdose are lethargy, disorder of respiratory drive, wheezing, sinus pause and bradycardia. Additionally, common efects associated with overdosage of any beta-adrenergic blocking agent and which might also be expected in Atenolol overdose are congestive heart failure, hypotension, bronchospasm and/or hypoglycemia. Treatment of overdose should be directed to the removal of any unabsorbed drug by induced emesis, gastric lavage, or administration of activated charcoal. Atenolol can be removed from the general circulation by hemodialysis. Based on the severity of symptoms, management may require intensive support care and facilities for applying cardiac and respiratory support.
Storage Conditions
Do not use later than the date of expiry. Keep all medicines out of the reach of children. To be dispensed only on the prescription of a registered physician.
Alternative brands of Atenolol
Other brands with the same generic name, cheapest first.